Cargando…
2542. Attenuation of Polymyxin and Aminoglycoside-Associated Nephrotoxicity
BACKGROUND: The clinical use of aminoglycosides and polymyxins to treat multidrug-resistant Gram-negative bacterial infections is hindered by dose-limiting nephrotoxicity. Recently, there has been increased interest in reducing the nephrotoxic potential of these antibiotics to combat the antimicrobi...
Autores principales: | Hudson, Cole, Smith, James E, Eales, Brianna, Liu, Xinli, Kajiji, Shama, Truong, Luan, Tam, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678801/ http://dx.doi.org/10.1093/ofid/ofad500.2159 |
Ejemplares similares
-
2767. Impact of iron limitation on in vitro and in vivo activity of ceftazidime against A. baumannii
por: Eales, Brianna, et al.
Publicado: (2023) -
Aminoglycoside-induced nephrotoxicity in children
por: McWilliam, Stephen J, et al.
Publicado: (2016) -
Assessing the Risk of Nephrotoxicity Associated With Non-renally Adjusted Intravenous Polymyxin B Compared with Traditional Dosing
por: Maniara, Bejoy, et al.
Publicado: (2017) -
500. Impact of an iron chelator on in vitro and in vivo growth of A. baumannii
por: Eales, Brianna, et al.
Publicado: (2022) -
Removing carbon catabolite repression in Parageobacillus thermoglucosidasius DSM 2542
por: Liang, Jinghui, et al.
Publicado: (2022)